Phase I Trial of Defactinib and VS-6766.

Clinical trial NCT03875820 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03875820
Sponsor: Institute of Cancer Research, United Kingdom
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

NSCLC Low Grade Serous Ovarian Cancer Endometrioid Carcinoma Pancreatic Cancer

Start date: 2017-12-12
Primary completion: 2023-04-30
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.